Abbott Laboratories Share Price Lima
Stocks
ABTUS
US0028241000
Medical Equipment, Supplies & Distribution
|
End-of-day quote
Other stock markets
|
5-day change | 1st Jan Change | ||
| 101.66 USD | 0.00% |
|
+1.66% | -22.75% |
| Market Cap | 182B 160B 149B 137B 257B 17,443B 261B 1,762B 690B 8,622B 683B 668B 29,822B | P/E 2026 * |
29.9x | P/E 2027 * | 23.1x |
|---|---|---|---|---|---|
| Enterprise Value | 206B 181B 169B 155B 291B 19,760B 296B 1,996B 782B 9,767B 774B 757B 33,781B | EV / Sales 2026 * |
4.1x | EV / Sales 2027 * | 3.72x |
| Free-Float |
86.73% | Yield 2026 * |
2.47% | Yield 2027 * | 2.62% |
Last Transcript: Abbott Laboratories
| 1 week | +1.66% | ||
| Current month | +15.34% | ||
| 1 month | +15.34% | ||
| 3 months | +11.55% | ||
| 6 months | -22.75% | ||
| Current year | -22.75% |
| 1 week | 101.66 |  | 101.66 |
| 1 month | 88.14 | | 101.66 |
| Current year | 82.56 | | 131.6 |
| 1 year | 82.56 | | 131.6 |
| 3 years | 82.56 | | 131.6 |
| 5 years | 82.56 | | 131.6 |
| 10 years | 82.56 | | 131.6 |
| Manager | Title | Age | Since |
|---|---|---|---|
Robert Ford
CEO | Chief Executive Officer | 52 | 30/03/2020 |
Philip Boudreau
DFI | Director of Finance/CFO | 53 | 31/08/2023 |
Sabina Ewing
CIO | Chief Investment Officer | 51 | - |
| Director | Title | Age | Since |
|---|---|---|---|
Sally Blount
BRD | Director/Board Member | 64 | 08/12/2011 |
Nancy McKinstry
BRD | Director/Board Member | 67 | 08/12/2011 |
Daniel Starks
BRD | Director/Board Member | 71 | 15/02/2017 |
| Change | 5-day change | 1-year change | 3-year change | Capi.($) | ||
|---|---|---|---|---|---|---|
 | 0.00% | +1.66% | - | - | 182B | |
| +3.16% | +4.31% | -6.52% | -1.84% | 108B | |
| +2.71% | +5.13% | +10.06% | +70.60% | 60.54B | |
| -4.21% | -6.07% | +22.50% | +49.01% | 50.53B | |
| +4.67% | +7.68% | -10.24% | -41.34% | 43.79B | |
| +2.04% | +4.19% | - | - | 33.57B | |
| +2.02% | -1.11% | -15.89% | -42.14% | 28.31B | |
| +1.74% | -4.35% | +27.89% | -5.04% | 23.31B | |
| +5.47% | +7.40% | -0.05% | +0.24% | 21.28B | |
| +1.78% | +0.95% | -11.55% | +0.68% | 20.27B | |
| Average | +1.58% | -1.01% | +2.02% | +3.77% | 43.27B | |
| Weighted average by Cap. | +0.76% | -0.24% | +1.57% | +9.69% |
| 2026 * | 2027 * | |
|---|---|---|
| Net sales | 50.3B 44.18B 41.21B 37.86B 70.94B 4,821B 72.13B 487B 191B 2,383B 189B 185B 8,243B | 54.65B 47.99B 44.77B 41.13B 77.07B 5,238B 78.36B 529B 207B 2,589B 205B 201B 8,954B |
| Net income | 6.25B 5.49B 5.12B 4.71B 8.82B 599B 8.97B 60.57B 23.73B 296B 23.48B 22.97B 1,025B | 7.92B 6.96B 6.49B 5.96B 11.17B 759B 11.36B 76.72B 30.06B 375B 29.74B 29.1B 1,298B |
| Net Debt | 24.17B 21.22B 19.8B 18.19B 34.08B 2,316B 34.65B 234B 91.67B 1,145B 90.72B 88.76B 3,960B | 21.42B 18.81B 17.55B 16.12B 30.2B 2,053B 30.71B 207B 81.24B 1,015B 80.39B 78.66B 3,509B |
| Date | Price | Change |
|---|---|---|
| 27/07/26 | US$101.66 | 0.00% |
| 24/07/26 | US$101.66 | 0.00% |
| 22/07/26 | US$101.66 | 0.00% |
| 21/07/26 | US$101.66 | +1.66% |
Trader
This super rating is the result of a weighted average of the rankings based on the following ratings: Valuation (Composite), EPS Revisions (4 months), and Visibility (Composite). We recommend that you carefully review the associated descriptions.
Investor
This super composite rating is the result of a weighted average of the rankings based on the following ratings: Fundamentals (Composite), Valuation (Composite), EPS Revisions (1 year), and Visibility (Composite). We recommend that you carefully review the associated descriptions.
Global
This composite rating is the result of an average of the rankings based on the following ratings: Fundamentals (Composite), Valuation (Composite), Financial Estimates Revisions (Composite), Consensus (Composite) and Visibility (Composite). The company must be covered by at least 4 of these 5 ratings for the calculation to be carried out. We recommend that you carefully review the associated descriptions.
Quality
This composite rating is the result of an average of rankings based on the following ratings: Returns (Composite), Profitability (Composite) and Quality of Financial Reporting (Composite), and Financial Health (Composite). The company must be covered by at least 2 of these 3 ratings for the calculation to be performed. We recommend that you carefully read the associated descriptions.
ESG MSCI
The MSCI ESG score assesses a company’s environmental, social, and governance practices relative to its industry peers. Companies are rated from CCC (laggard) to AAA (leader). This rating helps investors incorporate sustainability risks and opportunities into their investment decisions.
Quarterly revenue - Rate of surprise
- Stock Market
- Stocks
- ABT Stock
- ABTUS Stock
Select your edition
All financial news and data tailored to specific country editions
